PACB PacBio: Rasio cepet

Pacific Biosciences (PACB) is recognized as a global leader in developing systems for the detailed analysis of long genomic sequences, establishing the company as a reliable partner in science. This daily price chart, showing a value of 4.11, links this authority to a business model where the sale of consumables for equipment ensures a steady stream of profit. Meanwhile, Pacific Biosciences (PACB) optimizes expenses by outsourcing chip production to external semiconductor behemoths.

The quick ratio determines an issuer's ability to instantaneously settle short-term obligations without liquidating inventory. The trend of the quick ratio reflects the financial stability of the capital structure. The calculation is based on the sum of cash and accounts receivable divided by current liabilities. For Pacific Biosciences (PACB), this metric is critical, as high R&D expenses and competition create a risk of cash shortages.